Trial intelligence / Profile preview

Influenza vaccination response in patients with ANCA-associated vasculitis

ACTRN12608000440325Phase 4Completed

Sponsor
Royal Adelaide Hospital
Start
Apr 2007
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 4, open-label trial of influenza vaccine in influenza (2 arms), sponsored by Royal Adelaide Hospital. Primary endpoint: Immunological response to influenza vaccine. Started Apr 2007; status: completed.

02

Drugs

influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on ACTRN12608000440325.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12608000440325.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call